SCLP Share PerformanceMore

52 week high45.240 01/06/15
52 week low22.435 02/04/15
52 week change -7.250 (-23.58%)
4 week volume3,447,481 08/09/15

Media for (SCLP)

Presenter: Dr Richard Goodfellow
Presenter: Dr Richard Goodfellow

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Five stocks to cure your portfolio

The US personalised medicine market is tipped to be worth over $452 billion in 2015. These five British companies are fight...

Final Results for the year ended 30 April 2015

Announcement of full year/4th quarter financial results

ImmunoBody presented at Cancer Vaccines Conference

Notice of AGM

Notification of a company’s annual general meeting

General update and collaboration with ImmunID

Collaboration with ImmunID

Statement regarding an alliance between entities

Scancell says patient recruitment completed for SCIB1 trial

Scancell Holdings has closed patient recruitment for its SCIB1 ImmunoBody Phase 1/2 clinical trial in patients with Stage II...

Patient recruitment completed for SCIB1 trial

RNS Number: 5588S Scancell Holdings Plc 09 July 2015 09 July 2015 Scancell Holdings Plc Patient recruitment completed for SCIB1 Phase 1/2 clinical trial SCIB1 continues to deliver strong survival data in resected melanoma patients with Stage III/IV disease Scancell Holdings plc ('Scancell' or the 'Company'), the developer of novel immunotherapies for the treatment of ...